tyme technologies stock forum

TYME 033 001 424. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States.

Tyme Technologies Inc Tyme Stock Forum Discussion Yahoo Finance

TYME Technologies Inc.

. TYME stock quote history news and other vital information to help you with your stock trading and investing. Find the latest Tyme Technologies Inc. Stock TYME US90238J1034.

Find the latest Tyme Technologies Inc. Tyme Technologies stock was trading at 105 on March 11th 2020 when Coronavirus COVID-19 reached pandemic status according to the World Health Organization. Free forex prices toplists indices and lots more.

Message Board Total Posts. Tyme Technologies Inc is the US based clinical-stage biotechnology company. The Tyme Technologies Inc stock price fell by -515 on the last day Friday 8th Apr 2022 from 033 to 031.

Ad 1000 Strong Buy Stocks that Double the SP. Tyme Technologies Inc NASDAQ Updated Apr 7 2022 938 PM. The reporting person undertakes to provide to Tyme Technologies Inc any security holder of Tyme Technologies Inc or the staff of the Securities and Exchange Commission upon request full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The Companys lead clinical CMBT compound SM-88 is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic. Share your opinion and gain insight from other stock traders and investors. TYME Stock Message Board for Investors.

View which stocks have been most impacted by COVID-19. A high-level overview of Tyme Technologies Inc. Tyme Technologies Inc USTYME has 94 institutional owners and shareholders that have filed 13DG or 13F forms with the Securities Exchange Commission SEC.

Free forex prices toplists indices and lots more. Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. Our methodology considers analysis of the companys financial situation and how it has traded recently.

Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. Institutional Ownership and Shareholders. Tyme Technologies Inc TYME USD00001 Hargreaves Lansdown 2182022 TYME Technologies Inc.

SM 88 its proprietary drug candidate compound is a novel compound that has the. TYME Stock Analysis Overview. TYME the Company or TYME an emerging biotechnology company developing cancer metabolism-based therapies CMBTs today announced changes to its Board of.

TYME stock discussions in Yahoo Finances forum. Largest shareholders include Vanguard Group Inc VTSMX - Vanguard Total Stock Market Index. Tyme Technologies Inc Stock Symbol.

Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States. And has now fallen 3 days in a rowDuring the day the stock fluctuated 859 from a day low at 031 to a day high of 034The price has fallen in 6 of the last 10 days and is down by -1375 for this period. Share your opinion and gain insight from other stock traders and investors.

Is a biotechnology company. Our comprehensive analysis of fundamental and technical factors gives TYME a rank of 4. Tyme Technologies TYME stock price charts trades the USs most popular discussion forums.

Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Find the latest Tyme Technologies Inc. The Company is focused on developing cancer metabolism-based therapies CMBTs for a range of solid tumors and hematologic cancers.

Since then TYME shares have decreased by 668 and is now trading at 03489. These institutions hold a total of 16151006 shares. Announces SM-88 Poster at the American Association for Cancer Research AACR Annual Meeting 2022.

Tyme Technologies TYME gets a very poor rank from InvestorsObserver. Medical - Drugs Total Posts. TYME stock discussion in Yahoo Finances forum.

The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. Stock Price News and Company Updates. Friday June 11 2021 Futures UpDown Last Dow 7500 022 34429 SP 500 425 011 4233 Nasdaq 1350 009 13963 Stock futures are looking higher trying to build off yesterdays gains as the SP 500 Index posted its first closing high in over a month and as the Nasdaq Composite outperformed rising over 075 as the yield on the benchmark 10-year.

Tyme Technologies TYME stock price charts trades the USs most popular discussion forums. Forcasts revenue earnings analysts expectations ratios for TYME TECHNOLOGIES INC.

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Tyme Technologies My Bamboo Speculation In A Potential Leader In Cancer Metabolism Based Therapies Nasdaq Tyme Seeking Alpha

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Tyme Technologies Recent Sell Off Provides Opportunity To Buy At A Discount Nasdaq Tyme Seeking Alpha

Tyme Technologies Inc Tyme Stock Price And Discussion March 2022 Wallmine

Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Tyme Technologies Inc Tyme Stock Price And Discussion March 2022 Wallmine

Tyme Technologies Inc Tyme Stock Message Board Investorshub

Tyme Technologies Recent Sell Off Provides Opportunity To Buy At A Discount Nasdaq Tyme Seeking Alpha

N Csr 1 Filing788 Htm Primary Document United States Securities And Exchange Commission Washington D C 20549 Form N Csr Certified Shareholder Report Of Registered Management Investment Companies